These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 776199)

  • 1. Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.
    Joseph RR; Belpomme D; Mathé G
    Br J Cancer; 1976 May; 33(5):567-70. PubMed ID: 776199
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 4. The place of immunological methods of treatment in the management of acute leukaemia.
    Powles RL; Russell JA
    Hamatol Bluttransfus; 1976; 19():297-304. PubMed ID: 795744
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase in "Null" cells in acute lymphocytic leukemia in remission on long-term immunotherapy.
    Joseph RR; Belpomme D
    Recent Results Cancer Res; 1976; (56):72-8. PubMed ID: 1087444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are circulating null cells in patients submitted to long-term immunotherapy, related to K cells?
    Joseph RR; Lelarge N; Belpomme D
    Eur J Cancer (1965); 1977; 13(4-5):441-4. PubMed ID: 326557
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune complexes in children with leukemia: relationship to disease characteristics and to antibody response to Mycobacterium bovis (BCG) in patients receiving BCG immunotherapy.
    Minden P; Odom LF; Tubergen DG; Hardtke MA; Sharpton TR; Rose B; Zlotnick A; Carr RI
    Cancer; 1980 Feb; 45(3):460-8. PubMed ID: 6986198
    [No Abstract]   [Full Text] [Related]  

  • 8. BCG in the treatment of acute lymphocytic leukemia.
    Heyn RM; Joo P; Karon M; Nesbit M; Shore N; Breslow N; Weiner J; Reed A; Hammond D
    Blood; 1975 Sep; 46(3):431-42. PubMed ID: 1056801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
    Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H
    Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New results of active immunotherapy of acute lymphoid leukaemia.
    Mathé G; Pouillart P; Schwarzenberg L; Amiel JL; Schneider M; Hayat M; de Vassal F
    Bibl Haematol; 1973; 39():1115-24. PubMed ID: 4521516
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD; Yocum D; Yocum C
    Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Chemotherapy and B.C.G. in acute lymphocytic leukaemia.
    Ekert H; Jose DG
    Lancet; 1975 Oct; 2(7937):713-4. PubMed ID: 52092
    [No Abstract]   [Full Text] [Related]  

  • 13. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Hayat M; de Vassal F; Jasmin C; Rosenfeld C; Pouillart P
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):216-24. PubMed ID: 4997294
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunotherapy of acute infantile leukemia].
    De Bernardi B; Zanesco L; Carli M
    Minerva Med; 1972 Mar; 63(24):1468-70. PubMed ID: 4502510
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: K cells in leukaemia.
    Reid MM; Craft AW; Walker W
    Lancet; 1976 Sep; 2(7985):572. PubMed ID: 60644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of 10 years of experiments with immunotherapy of acute leukemia with Polish BCG vaccine].
    Kardaszewicz E; Japa J
    Pol Arch Med Wewn; 1980 Jan; 63(1):39-44. PubMed ID: 6928602
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.
    Mathé G; De Vassal F; Schwarzenberg L; Delgado M; Weiner R; Gil MA; Pena-Angulo J; Belpomme D; Pouillart P; Machover D; Misset JL; Pico JL; Jasmin C; Hayat M; Schneider M; Cattan A; Amiel JL; Musset M; Rosenfeld C; Ribaud P
    Med Pediatr Oncol; 1978; 4(1):17-27. PubMed ID: 272482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Active immunotherapy in acute lymphoid leukemia in children. Influence of several factors on the results].
    Mathe G; Pouillart P; Schwarzenberg L; Hayat M; Schneider M; Weiner R; Amiel JL; Jasmin G; de Vassal F; Cattan A
    Arch Fr Pediatr; 1973 Jan; 30(1):65-81. PubMed ID: 4516058
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG and cancer.
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.